Skip to content

The effect of low intensity focused ultrasound on myofascial pain syndrome

The effect of low intensity focused ultrasound on myofascial pain syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097431
Enrollment
Unknown
Registered
2025-02-19
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain syndrome

Interventions

Trial group:LIFU
Control group:Non-focused ultrasound therapy

Sponsors

West China Hospital,Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.20-70 years old; 2. Meet the diagnostic criteria for MPS in the Diagnosis and Treatment of Myofascial Pain Syndrome: meet 5 major criteria and at least 1 minor criterion

Exclusion criteria

Exclusion criteria: 1. Pregnant women or those trying to become pregnant; 2.Radiation-induced pain in the upper/lower extremities due to disc herniation; 3.spinal infection, fracture and tumor; 4.Active period of rheumatoid arthritis and ankylosing spondylitis; 5.have received biological therapies such as stem cells in the past year; 6.Steroid injection within 1 month; 7.Taking systemic immunosuppressive drugs within the past year; 8.Taking anti-rheumatic drugs in the past 3 months; 9.Have received needle-knife therapy, Chinese herbal medicine and other treatments in the past 3 months; 10.Have received acupuncture, cupping and other treatments in the past 2 weeks; 11. Complicated cardiovascular and cerebrovascular diseases, such as myocardial infarction, heart failure, uncontrolled hypertension (180/90mmHg), stroke, TIA, kidney, liver and other organ failure, etc.; 12.Infectious diseases such as tuberculosis, HIV, hepatitis and syphilis; 13.unexplained fever > 38.0?; 14.Participate in drug and device research within one year; 15.is participating in litigation; 16.A history of alcohol and drug abuse; 17.moderate to severe anxiety, depression and other mental illness; 18.Unable to understand Mandarin and Chinese characters.

Design outcomes

Primary

MeasureTime frame
VAS Score;

Secondary

MeasureTime frame
Functional evaluation;sEMG result;Analgesic drug use;

Countries

China

Contacts

Public ContactQian Wang

West China Hospital,Sichuan University

wangqianwind@163.com+86 135 5180 7962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026